This report deals with a patient with long standing myasthenia gravis treated with a small dose of corticosteroids. The response to treatment was prompt and the post-therapeutic deterioration in function was minimal and cholinergic in nature. It is suggested that the dose of anticholinesterases be reduced concomitantly with the institution of steroid treatment.
Introduction
Steroids and adrenocorticotrophic hormone (ACTH) have been used increasingly in the treatment of myasthenia gravis during the past few years, and this subject has been reviewed by Brunner, Namba and Grob (1972) , Cape and Utterback (1972) , Turner (1974) and Liversedge et al. (1974) .
The prime indication for the use of steroids/ACTH in myasthenia is the progressive diminution in the efficacy of anticholinesterases (prostigmine and pyridostigmine) which develops in some patients. Two (1972) noted that their patients' weakness did not respond to anticholinesterases during this phase. Brunner et al. (1972) found that anticholinesterases either had no effect or in fact caused a further decrease in the muscular strength of their patients at this stage. Turner (1974) and Liversedge et al. (1974) , do not comment upon the effect of anticholinesterases during this phase.
In the rat phrenic nerve-diaphragm preparation, prednisolone has been shown experimentally to enhance the release of acetylcholine at the neuromuscular junction; in addition, it has a direct stimulatory effect upon the sarcolemmal membrane (Wilson, Ward and Johns, 1974 ). An increase in the sensitivity of the sarcolemmal membrane in myasthenics may also occur in fashion similar to that observed in the denervated muscle (Miledi, 1960) since the quantity of acetylcholine released at the neuromuscular junction of these patients is considerably diminished (Elmqvist et al., 1964) . Furthermore, steroids may inhibit the binding to acetylcholine receptors of IgG which occurs in myasthenics (Bender et al., 1975) ; this would make more acetylcholine receptors available thus rendering the sarcolemmal membrane more sensitive to acetylcholine. It is suggested that a combination of the mechanisms described above would account for both the beneficial effect and the subsequent cholinergic crisis in these patients following treatment with steroids.
If these mechanisms do underlie both the beneficial and the hazardous effects of corticosteroid therapy, it would seem that all patients who have a post-therapy cholinergic crisis should eventually benefit from this treatment. This has been the experience of Genkins, Kornfeld and Osserman (1971) who considered that such deterioration initially was a good prognostic feature in 100 myasthenic patients treated with ACTH.
In the present patient the cholinergic crisis improved without reduction of the dose of pyridostigmine initially, although later the drug was successfully withdrawn completely. This suggests that the heightened sensitivity of the sarcolemmal membrane to acetylcholine is rapidly reversible, but the authors know of no experimental observations to support this concept.
If further studies show that deterioration following corticosteroid therapy can be ascribed to excessive cholinergic activity in all or most patients, the wisdom of giving large doses of steroids (or ACTH) in combination with the usual, large doses of anticholinesterases would have to be reconsidered.
The association of pseudomembranous enterocolitis with antibiotic therapy is well recognized (Leading Article, 1975; Tedesco, Barton and Alpers, 1974 toid arthritis had been diagnosed in 1967 when she had a successful left hip replacement, and since then she had been taking prednisolone 2-5 mg b.d. Cover for the operation included hydrocortisone 100 mg 6-hourly, ampicillin 250 mg 6-hourly and cloxacillin 500 mg 6-hourly. Both antibiotics were continued for 23 days. Initial postoperative progress was uneventful, but on the seventh day she developed dysuria and pyrexia; urine culture grew Klebsiella aerogenes resistant to ampicillin. Co-trimoxazole produced an immediate hypotensive reaction, with an itchy erythematous rash and generalized oedema; it was withdrawn after one dose. Nitrofurantoin 100 mg q.i.d. for 10 days cleared the infection, and subsequent urine and blood cultures were not infected.
From the tenth postoperative day diarrhoea and vomiting became a problem. The vomiting stopped when the ampicillin and cloxacillin were given intramuscularly, but loose watery stools continued up to six times a day with faecal incontinence at night. The wound edges were necrotic but clean. The antibiotics were stopped and intravenous fluids started on the twenty-third postoperative day. Seven days later she developed a pyrexia and slime was noticed in the motions. Sigmoidoscopy showed numerous
